Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS , and TDP ‐43 fibrils: A molecular dynamics study
Proteins: Structure, Function, and Bioinformatics · 2024
DOI: 10.1002/prot.26679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proteins: Structure, Function, and Bioinformatics, 2024. Verfasst von Noah Nathan Kochen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, alpha-Synuclein, Hydrophobic and Hydrophilic Interactions, Protein Processing, Post-Translational. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Hydration plays a crucial role in the refolding of intrinsically disordered proteins into amyloid fibrils; however, the specific interactions between water and protein that may contribute to this process are still unknown. In our previous studies of alpha‐synuclein (aSyn), we have shown that waters confined in fibril cavities are stabilizing features of this pathological fold; and that amino acids that hydrogen bond with these confined waters modulate primary and seeded aggregation. Here, we extend our aSyn molecular dynamics (MD) simulations with three new polymorphs and correlate MD trajectory information with known post‐translational modifications (PTMs) and experimental data. We show that cavity residues are more evolutionarily conserved than non‐cavity residues and are enriched with PTM sites. As expected, the confinement within hydrophilic cavities results in more stably hydrated amino acids. Interestingly, cavity PTM sites display the longest protein‐water hydrogen bond lifetimes, three‐fold greater than non‐PTM cavity sites. Utilizing the deep mutational screen dataset by Newberry et al. and the Thioflavin T aggregation review by Pancoe et al. parsed using a fibril cavity/non‐cavity definition, we show that hydrophobic changes to amino acids in cavities have a larger effect on fitness and aggregation rate than residues outside cavities, supporting our hypothesis that these sites are involved in the inhibition of aSyn toxic fibrillization. Finally, we expand our study to include analysis of fibril structures of tau, FUS, TDP‐43, prion, and hnRNPA1; all of which contained hydrated cavities, with tau, FUS, and TDP‐43 recapitulating our PTM results in aSyn fibril cavities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Noah Nathan Kochen
Förderung
- NINDS NIH HHS
- NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Kochen, N. N., Seaney, D., Vasandani, V., Murray, M., Braun, A. R., & Sachs, J. N. (2024). Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS , and TDP ‐43 fibrils: A molecular dynamics study. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26679
Vancouver
Kochen NN, Seaney D, Vasandani V, Murray M, Braun AR, Sachs JN. Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS , and TDP ‐43 fibrils: A molecular dynamics study. Proteins: Structure, Function, and Bioinformatics. 2024. doi:10.1002/prot.26679
BibTeX
@article{Kochen2024,
author = {Kochen, Noah Nathan and Seaney, Darren and Vasandani, Vivek and Murray, Marguerite and Braun, Anthony R and Sachs, Jonathan N},
title = {Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS , and TDP ‐43 fibrils: A molecular dynamics study},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2024},
doi = {10.1002/prot.26679}
}
EUVIMED